Presentation
7 March 2022 Blue light is a multi-purpose antibiotic adjuvant that synergizes with conventional antibiotic therapy
Leon G. Leanse, Carolina dos Anjos, Tianhong Dai
Author Affiliations +
Abstract
Antimicrobial resistance has necessitated the investigation of novel approaches to prolong the use of conventional antibiotics. We hypothesized that using the innovative ‘drug-free’ approach, antimicrobial blue light (aBL), which is a selective generator of ROS in bacteria, we can exploit increases in intracellular ROS to synergize to conventional antibiotics, given that they share a parallel pathway of bactericidal activity. Studies from our group have also suggested the adjuvant potential of aBL that may further promote the effectiveness of antibiotics. Here, we explored the synergistic and adjuvant effects of aBL using different antibiotic classes against bacteria, in vitro and in vivo.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Leon G. Leanse, Carolina dos Anjos, and Tianhong Dai "Blue light is a multi-purpose antibiotic adjuvant that synergizes with conventional antibiotic therapy", Proc. SPIE PC11939, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2022, PC1193906 (7 March 2022); https://doi.org/10.1117/12.2609760
Advertisement
Advertisement
KEYWORDS
Bacteria

Phototherapy

Resistance

In vitro testing

Light emitting diodes

Medicine

Microorganisms

Back to Top